This Article  • References  • Full text PDF  • Reply to article  • Send to a friend  • Save in My Folder  • Save to citation manager  • Permissions  Citing Articles  • Citation map  • Citing articles on HighWire  • Citing articles on Web of Science (1)  • Contact me when this article is cited  Related Content  • Similar articles in this journal  Social Bookmarking   What's this?

Who Pays the Price for Medical Progress?

Steven J. Smith, PhD; Jerod M. Loeb, PhD; R. Mark Evans, PhD; William R. Hendee, PhD

Arch Ophthalmol. 1988;106(9):1184-1187.

	Since this article does not have an abstract, we have provided the first 150 words of the full text PDF and any section headings.

A heated public debate on the use of animals in biomedical research is being waged by proponents and opponents of animal research. The primary issue is the answer to a single fundamental question: Are Americans willing to allow the use of animals in biomedical research that aims to ease the suffering and prolong and improve the quality of the lives of millions of humans and animals? This article explores the threat to biomedical research posed by laws that restrict the use of animals in research and discusses federal legislation, American Medical Association (AMA) initiatives, and areas of controversy. The issue of animal use for toxicity tests such as the Draize test and the lethal dose for 50% survival of group (LD₅₀) test is also addressed.

Few scientists wish to utilize animals in research studies. However, they recognize that the needed results cannot at present, nor in the foreseeable future, . . . [Full Text PDF of this Article]

Author Affiliations
American Medical Association 535 N Dearborn St Chicago, IL 60610

CiteULike    Connotea    Del.icio.us    Digg    Reddit    Technorati    Twitter     What's this?